THUNDER BIOTECH INC has a total of 14 patent applications. It decreased the IP activity by 57.0%. Its first patent ever was published in 2016. It filed its patents most often in United States, Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are IMMUNWORK INC, ISU ABXIS CO LTD and STEM CENTRX INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 3 | |
#2 | Australia | 2 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | South Africa | 2 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | EPO (European Patent Office) | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms | |
#5 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | O'Neill Kim | 12 |
#2 | Weber Scott | 3 |
#3 | O'Neill Kim Leslie | 2 |
Publication | Filing date | Title |
---|---|---|
WO2019135879A1 | Modified macrophages and macrophage precursors and associated methods | |
WO2018212770A1 | Transgenic macrophages, chimeric antigen receptors, and associated methods | |
US2018334653A1 | Transgenic macrophages, chimeric antigen receptors, and associated methods | |
AU2016305353A1 | Macrophage chimeric antigen receptor (MOTO-CAR) in imunotherapy |